Transparency Market Research Report Added "Pharmerging Market" to its database.

Albany, NY -- (SBWire) -- 01/21/2016 --A new market research report by Transparency Market Research, titled "Pharmerging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", provides a detailed analysis of the growth of the pharmerging market across the globe. The report studies the various factors affecting the growth of the global pharmerging market and estimates the growth trajectory exhibited by the market during the period between 2015 and 2023. The report further studies the growth of the market across key regions. Profiles of some of the prominent players operating in the global pharmerging market have been included in the report along with information about mergers, acquisitions, and partnerships among the players.

Browse Full Report: http://www.transparencymarketresearch.com/pharmerging-market.html

The report points out that the declining rate of pharmaceutical sales growth across matured markets has been due to patent expirations and availability of low cost generics. The introduction of new molecular entities is expected to further shrink the pharmaceutical sales in matured markets. With research and development activities being time-consuming and costly, pharmaceutical companies are looking at the pharmerging market. This will propel the growth of the global pharmerging market. However, one of the biggest challenges faced by pharmaceutical companies is pricing pressure, which impacts the profit margin of the companies.

The pharmerging market in China has emerged as the largest and the fastest growing pharmaceutical market. The growing healthcare spending by the Chinese government and implementation of the four year plan (2012 – 2015) for the prevention and control of chronic diseases has propelled the pharmerging market in China. The pharmerging market across India, Brazil and Russia is expected to be driven by rising government healthcare expenditure, growing geriatric population, and increasing prevalence of chronic diseases. In the coming years, the BRIC nations are expected to lead the overall market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8200

The report profiles some of the key players in the global pharmerging market such as Amgen Inc., Abbott Laboratories, Merck & Co Inc., Bristol-Myers Squibb Co, Novartis International AG, Boehringer Ingelheim Pharmaceuticals Corporation, AstraZeneca plc, Bayer HealthCare AG, Sanofi S.A., Novo Nordisk A/S., Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, and Eli Lilly and Co. The key players are focusing on mergers and acquisitions. For example, Abbott Laboratories acquired Piramal Healthcare in 2010, thereby emerging as a leader in the Indian pharmaceutical market. Eli Lilly entered into a strategic partnership with Chinese manufacturer Novast Laboratories Ltd. in 2011 to offer high-quality generic medicines to Chinese patients. Multinational pharmaceutical firms are stressing on developing their manufacturing and research facilities. However, these pharmaceutical firms need to lower their prices to compete in local markets.

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/